BioSpace News Archive

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people who may be affected by severe weather and flooding across parts of Louisiana, Texas and Mississippi as a result of Tropical Storm Barry.

The global selective serotonin reuptake inhibitors market is expected to post a CAGR of close to 4% during the period 2019-2023, according to the latest market research report by Technavio.

PharmaCentra, LLC, Concentra Solutions, Inc. and CannabisBPO are pleased to announce the appointment of their Chief Executive Officer and Founder, Daniel Berman, to The Carter Center’s Board of Councilors.

An international group of experts today presented data demonstrating how select phytomedicines can reduce migraine headache attacks.

At Health Canada’s request, Nutrabolics Inc. is voluntarily recalling “Blackout,” a sleep-aid product, because it is labelled to contain a drug (L-tryptophan) at a prescription-strength dose, and may pose serious health risks.

City of Hope’s Fouad R. Kandeel, M.D., Ph.D., has been named the inaugural recipient of the Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research.

The healthcare technology company now able to offer primary source verification

The Know Now Testing Program, a Novartis initiative in collaboration with Quest Diagnostics, offers genetic mutation testing at no cost for all patients with stage III or stage IV melanoma.

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that two oral and 13 poster presentations about its Alzheimer’s Disease (AD), dementia pipeline will be presented at the 2019 Alzheimer’s Association International Conference (AAIC), July 14-18, in Los Angeles.

Today, the national law firm of Baron & Budd announced that a False Claims Act (FCA) lawsuit it filed against London-based Reckitt Benckiser Group plc (RBG) is part of a total $1.4 billion settlement, the largest settlement to date against an opioid manufacturer. Of the $1.4 billion, $700 million is a settlement of civil claims brought under the FCA.